| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |